Russell Investments Group Ltd. Decreases Stock Holdings in Transcat, Inc. (NASDAQ:TRNS)

Russell Investments Group Ltd. trimmed its position in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 72.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,571 shares of the scientific and technical instruments company's stock after selling 14,700 shares during the period. Russell Investments Group Ltd. owned about 0.06% of Transcat worth $589,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in TRNS. Raymond James Financial Inc. acquired a new stake in Transcat during the 4th quarter worth $2,071,000. JPMorgan Chase & Co. raised its stake in Transcat by 153.1% during the 4th quarter. JPMorgan Chase & Co. now owns 26,434 shares of the scientific and technical instruments company's stock worth $2,795,000 after acquiring an additional 15,991 shares in the last quarter. Barclays PLC raised its stake in Transcat by 393.0% during the 3rd quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company's stock worth $1,826,000 after acquiring an additional 12,061 shares in the last quarter. Geode Capital Management LLC raised its stake in Transcat by 5.4% during the 3rd quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company's stock worth $26,269,000 after acquiring an additional 11,106 shares in the last quarter. Finally, Rice Hall James & Associates LLC raised its stake in Transcat by 40.2% during the 4th quarter. Rice Hall James & Associates LLC now owns 35,685 shares of the scientific and technical instruments company's stock worth $3,773,000 after acquiring an additional 10,238 shares in the last quarter. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

Transcat Stock Performance

TRNS traded down $4.15 during trading on Monday, hitting $80.98. The stock had a trading volume of 98,370 shares, compared to its average volume of 74,296. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42. The firm has a market capitalization of $753.84 million, a P/E ratio of 43.77 and a beta of 0.67. The company's 50-day moving average price is $77.08 and its 200 day moving average price is $93.89. Transcat, Inc. has a twelve month low of $67.56 and a twelve month high of $147.12.

Transcat (NASDAQ:TRNS - Get Free Report) last announced its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same period in the previous year, the company posted $0.56 EPS. On average, equities research analysts forecast that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Insider Buying and Selling at Transcat

In other news, Director Craig D. Cairns acquired 1,200 shares of the company's stock in a transaction on Friday, January 31st. The shares were bought at an average cost of $77.02 per share, with a total value of $92,424.00. Following the purchase, the director now owns 1,910 shares of the company's stock, valued at $147,108.20. This represents a 169.01 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 2.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Oppenheimer lowered shares of Transcat from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 29th. StockNews.com downgraded shares of Transcat from a "hold" rating to a "sell" rating in a research report on Wednesday, February 5th. HC Wainwright lowered their price objective on shares of Transcat from $126.00 to $106.00 and set a "buy" rating on the stock in a research report on Wednesday, January 29th. Finally, Northland Securities reissued a "market perform" rating and set a $85.00 price objective (down from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $111.50.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.